4d Molecular Therapeutics, Inc. · NASDAQ:FDMT
State Street Corp reported a 5.30% stake in 4d Molecular Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 12, 2026
State Street Corp reported a 5.30% stake in 4d Molecular Therapeutics, Inc., 2,707,875 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 2,707,875
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.30% | 2,707,875 |